Interview with Dr. Barry Bedell
FACE TO FACE with Dr. Barry Bedell: A multimodal vision for the SAIL Platform
Dr. Jean-Pierre Routy’s team receives new CIHR funding for innovative HIV/AIDS research
Congratulations to Dr. Jean-Pierre Routy and his team from the Research Institute of the MUHC and McGill University on being awarded a...
How a few drops of blood led to a breakthrough in immunology
Scientists from the Research Institute of the McGill University Health Centre (RI-MUHC) may have cracked the code to understanding...
Biofilms—the eradication has begun
Have you ever heard of biofilms? They are slimy, glue-like membranes that are produced by microbes, like bacteria and fungi, in order to...
Interview with Dr. Don Sheppard
Touching down in Frankfurt en route to Beirut to deliver a lecture on human fungal disease, Dr. Don Sheppard willingly makes time to share...
Doctoral student Necola Guerrina: Connecting basic respiratory research with clinical needs
Necola Guerrina is unlikely to become the stereotypical solitary scientist. This doctoral student in pathology has a talent for communication and collaboration...
On the genetics trail
Researchers have identified the genetic mutation responsible for one patient's serious health problems, finally solving a medical...
New marker and potential therapy for triple negative breast cancer
Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, found in 15-20% of all cases. These breast tumors are...
A surprise advance in the treatment of adult cancers
A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of...
New marker identified for pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Due to its deep anatomical location, tumour-specific symptoms typically occur only...